Extending the scope of PARP inhibitors in ovarian cancer

被引：7
|
作者：
Ledermann, Jonathan A. [1 ,2 ]
机构：
[1] UCL, Canc Res UK, UCL Canc Inst, London W1T 41J, England
[2] UCL, UCL Canc Trials Ctr, UCL Canc Inst, London W1T 41J, England
来源：
LANCET ONCOLOGY | 2019年 / 20卷 / 04期
关键词：
D O I：
10.1016/S1470-2045(19)30019-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：470 / 472
页数：3
相关论文
共 50 条
  • [31] Using PARP Inhibitors in Advanced Ovarian Cancer
    O'Cearbhaill, Roisin E.
    [J]. ONCOLOGY-NEW YORK, 2018, 32 (07): : 339 - 343
  • [32] The Current Landscape of PARP Inhibitors in Ovarian Cancer
    Camille C. Gunderson
    Britt K. Erickson
    Megan E. Buechel
    Kathleen N. Moore
    [J]. Current Obstetrics and Gynecology Reports, 2018, 7 (1) : 20 - 27
  • [33] PARP inhibitors in the treatment of ovarian cancer: a review
    Washington, Christina R.
    Moore, Kathleen N.
    [J]. CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2021, 33 (01) : 1 - 6
  • [34] PARP inhibitors and quality of life in ovarian cancer
    Aoki, Daisuke
    Chiyoda, Tatsuyuki
    [J]. LANCET ONCOLOGY, 2018, 19 (08): : 1012 - 1014
  • [35] PARP inhibitors for targeted treatment in ovarian cancer
    Dizon, Don S.
    [J]. LANCET, 2017, 390 (10106): : 1929 - 1930
  • [36] Latest development of PARP inhibitors in ovarian cancer
    Harano, Kenichi
    [J]. ANNALS OF ONCOLOGY, 2019, 30
  • [37] Appropriate Selection of PARP Inhibitors in Ovarian Cancer
    Smith, Maria
    Pothuri, Bhavana
    [J]. CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2022, 23 (06) : 887 - 903
  • [38] Appropriate Selection of PARP Inhibitors in Ovarian Cancer
    Maria Smith
    Bhavana Pothuri
    [J]. Current Treatment Options in Oncology, 2022, 23 : 887 - 903
  • [39] PARP Inhibitors in Newly Diagnosed and Recurrent Ovarian Cancer
    Giannini, Andrea
    Di Dio, Camilla
    Di Donato, Violante
    D'oria, Ottavia
    Salerno, Maria Giovanna
    Capalbo, Giuseppe
    Cuccu, Ilaria
    Perniola, Giorgia
    Muzii, Ludovico
    Bogani, Giorgio
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2023, 46 (09): : 414 - 419
  • [40] Using PARP Inhibitors in the Treatment of Patients With Ovarian Cancer
    Kurnit, Katherine C.
    Coleman, Robert L.
    Westin, Shannon N.
    [J]. CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2018, 19 (12)
12345